Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2024-12-10 | New | $3,000,000 | $3,000,000 | Equity Only | 06b | SEC link |
| 2022-10-21 | New | $6,047,456 | $6,047,456 | Equity Only | 06b | SEC link |
| 2020-12-29 | New | $3,999,955 | $3,999,955 | Equity Only | 06b | SEC link |
| 2019-12-16 | New | $1,000,000 | $1,000,000 | Debt Only | 06b | SEC link |
| 2018-12-03 | New | $709,095 | $709,095 | Equity Only | 06b | SEC link |
| 2018-05-03 | Amended | $357,065 | $49,999 | Equity and Debt | 06b | SEC link |
| 2018-03-30 | New | $307,066 | $307,066 | Equity and Debt | 06b | SEC link |
| Name | Role |
|---|---|
| John Byrnes | Director |
| Brian Gagne | Executive |
| Dennis Hodges | Executive |
| Asif Naseem | Director, Executive |
| Chad Raube | Director |
| Bradley Simmons | Director |
| Yi Zhang | Director |